Starts & Stops: CardioFocus Studies HeartLight X3 In Persistent AF; IntraLink Spine Launches Trial Of Low-Back Device In Australia

17 Mar 2019

• By Reed Miller

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from March 4 through March 17, including trial announcements from CardioFocus, Innovative Cardiovascular Solutions, IntraLink-Spine, Geneveve, Acutus, and Stereotaxis.

[Editors Note: Starts & Stops is Medtech Insight’s regular review of important medical device trial announcements as tracked by Informa’s MedDeviceTracker. Click here to request a demonstration. For an archive of previous Starts & Stops and Results Recap, MTI's regular updates on trial outcomes, visit the Tracking Trials page.]

A 60-patient clinical study evaluating CardioFocus’ HeartLight X3 laser balloon ablation catheter for treatment of persistent atrial fibrillation has...